Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical

2009 Biopharma Deals Of The Year: Roche/Genentech, Movetis' IPO, Elan/J&J

  • Analysis

Executive Summary

Which pharmaceutical and biotech deal-making and financing developments of the past year are the most surprising, creative or precedent-setting

You may also be interested in...



Financings Of The Fortnight: Movetis Files First European Biopharma IPO Since Early 2008

Notable biotech financings in November also include ThromboGenics, NicOx: 4SC AG, and Fate Therapeutics.

A Solution For Elan: It Strikes A Deal With J&J On Key Alzheimer's Assets

J&J gets to build its fledgling Alzheimer's program, while Elan gets cash to strengthen its balance sheet, plus a new minority shareholder and strong global partner.

Roche Wins Genentech After Months-Long Battle

The hard task of integration—and the battle to retain Genentech employees—begins, while the DNA ticker symbol is up for grabs.

Table

View full table

Topics

Tags:
BioPharmaceutical
UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By